BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fukudo S, Okumura T, Inamori M, Okuyama Y, Kanazawa M, Kamiya T, Sato K, Shiotani A, Naito Y, Fujikawa Y, Hokari R, Masaoka T, Fujimoto K, Kaneko H, Torii A, Matsueda K, Miwa H, Enomoto N, Shimosegawa T, Koike K. Evidence-based clinical practice guidelines for irritable bowel syndrome 2020. J Gastroenterol 2021;56:193-217. [PMID: 33538894 DOI: 10.1007/s00535-020-01746-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Chen Q, Zhang H, Sun CY, He QY, Zhang RR, Luo BF, Zhou ZH, Chen XF. Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome. Mol Med 2023;29:5. [PMID: 36635623 DOI: 10.1186/s10020-022-00599-x] [Reference Citation Analysis]
2 Koseki T, Muratsubaki T, Tsushima H, Morinaga Y, Oohashi T, Imafuku M, Suzuki Y, Kanazawa M, Fukudo S. Impact of mindfulness tendency and physical activity on brain-gut interactions. J Gastroenterol 2023;58:158-70. [PMID: 36629949 DOI: 10.1007/s00535-022-01938-9] [Reference Citation Analysis]
3 Nakata R, Tanaka F, Sugawara N, Kojima Y, Takeuchi T, Shiba M, Higuchi K, Fujiwara Y. Analysis of autonomic function during natural defecation in patients with irritable bowel syndrome using real-time recording with a wearable device. PLoS One 2022;17:e0278922. [PMID: 36490298 DOI: 10.1371/journal.pone.0278922] [Reference Citation Analysis]
4 Chojnacki C, Medrek-Socha M, Blonska A, Zajdel R, Chojnacki J, Poplawski T. A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites. Int J Mol Sci 2022;23. [PMID: 36499643 DOI: 10.3390/ijms232315314] [Reference Citation Analysis]
5 Sanz Morales P, Wijeyesekera A, Robertson MD, Jackson PPJ, Gibson GR. The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome. Microorganisms 2022;10. [PMID: 36557589 DOI: 10.3390/microorganisms10122338] [Reference Citation Analysis]
6 Brenner DM, Lacy BE, Ford AC, Bartolini W, Wu J, Shea EP, Bochenek W, Boinpally R, Almansa C. Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials. Am J Gastroenterol 2022. [PMID: 36227782 DOI: 10.14309/ajg.0000000000002064] [Reference Citation Analysis]
7 Camilleri M, Boeckxstaens G. Irritable bowel syndrome: treatment based on pathophysiology and biomarkers. Gut 2022:gutjnl-2022-328515. [PMID: 36307180 DOI: 10.1136/gutjnl-2022-328515] [Reference Citation Analysis]
8 Wang Y, Chen N, Niu F, Li Y, Guo K, Shang X, E F, Yang C, Yang K, Li X. Probiotics therapy for adults with diarrhea-predominant irritable bowel syndrome: a systematic review and meta-analysis of 10 RCTs. Int J Colorectal Dis 2022. [PMID: 36251040 DOI: 10.1007/s00384-022-04261-0] [Reference Citation Analysis]
9 Hershko-moshe A, Hasin Y, Nevo-shor A, Etzion O, Ilan Y. Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance. GastroHep 2022;2022:1-12. [DOI: 10.1155/2022/1192547] [Reference Citation Analysis]
10 Hou Y, Zhao Y, Jiang H, Wang K, Zhang W, Zhou S, Li Y, Zheng Q. Maintenance of Intestinal Homeostasis in Diarrhea-Predominant Irritable Bowel Syndrome by Electroacupuncture Through Submucosal Enteric Glial Cell-Derived S-Nitrosoglutathione. Front Physiol 2022;13:917579. [DOI: 10.3389/fphys.2022.917579] [Reference Citation Analysis]
11 Zhan T, Dong Z, Yi L, Zhang Y, Sun H, Zhang H, Wang J, Chen Y, Huang Y, Xu S. Tandospirone prevents stress-induced anxiety-like behavior and visceral hypersensitivity by suppressing theta oscillation enhancement via 5-HT1A receptors in the anterior cingulate cortex in rats. Front Cell Neurosci 2022;16:922750. [DOI: 10.3389/fncel.2022.922750] [Reference Citation Analysis]
12 Shrestha B, Patel D, Shah H, Hanna KS, Kaur H, Alazzeh MS, Thandavaram A, Channar A, Purohit A, Venugopal S. The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review. Cureus 2022. [DOI: 10.7759/cureus.28064] [Reference Citation Analysis]
13 Kobayashi K, So Y, Yamada T, Fujii Y. Use of a cognitive behavioral therapy-based mobile application for non-patients with irritable bowel syndrome: preliminary evidence of effectiveness.. [DOI: 10.21203/rs.3.rs-1920985/v1] [Reference Citation Analysis]
14 Lu Q, Tan D, Luo J, Ye Y, Zuo M, Wang S, Li C. Potential of natural products in the treatment of irritable bowel syndrome. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154419] [Reference Citation Analysis]
15 Sharifi M, Safarpour AR, Barati-Boldaji R, Rahmati L, Karimi S, Bagheri Lankaran K. Post-Infectious Irritable Bowel Syndrome after an Epidemic of Gastroenteritis in South of Iran. Middle East J Dig Dis 2022;14:304-9. [PMID: 36619262 DOI: 10.34172/mejdd.2022.287] [Reference Citation Analysis]
16 Okazaki Y, Yoshida S, Kashima S, Miyamori D, Matsumoto M. Increased prescriptions for irritable bowel syndrome after the 2018 Japan Floods: a longitudinal analysis based on the Japanese National Database of Health Insurance Claims and Specific Health Checkups. BMC Gastroenterol 2022;22:263. [PMID: 35619078 DOI: 10.1186/s12876-022-02342-6] [Reference Citation Analysis]
17 Maev IV, Osadchuk MA, Burdina VO, Mironova ED, Osadchuk MM. The Role of Endocrine Cells of the Colon, Secreting Vasoactive Intestinal Polypeptide, Somatostatin and Motilin, in Irritable Bowel Syndrome, Occurring with Diarrhea and Constipation. Annals RAMS 2022;77:79-86. [DOI: 10.15690/vramn2030] [Reference Citation Analysis]
18 Oliveira J E Silva L, Prakken SD, Meltzer AC, Broder JS, Gerberi DJ, Upadhye S, Carpenter CR, Bellolio F. Depression and anxiety screening in emergency department patients with recurrent abdominal pain: An evidence synthesis for a clinical practice guideline. Acad Emerg Med 2022;29:615-29. [PMID: 34665903 DOI: 10.1111/acem.14394] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zhang T, Zhang C, Zhang J, Sun F, Duan L. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis. Front Cell Infect Microbiol 2022;12:859967. [DOI: 10.3389/fcimb.2022.859967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Siqueira-Campos VM, de Deus MSC, Poli-Neto OB, Rosa-E-Silva JC, de Deus JM, Conde DM. Current Challenges in the Management of Chronic Pelvic Pain in Women: From Bench to Bedside. Int J Womens Health 2022;14:225-44. [PMID: 35210869 DOI: 10.2147/IJWH.S224891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yakovenko EP, Strokova TV, Ivanov AN, Iakovenko AV, Gioeva IZ, Aldiyarova MA. The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study. Terapevticheskii arkhiv 2022;94:180-7. [DOI: 10.26442/00403660.2022.02.201368] [Reference Citation Analysis]
22 Mohseni F, Agah S, Ebrahimi-daryani N, Taher M, Nattagh-eshtivani E, Karimi S, Rastgoo S, Bourbour F, Hekmatdoost A. The effect of low FODMAP diet with and without gluten on irritable bowel syndrome: A double blind, placebo controlled randomized clinical trial. Clinical Nutrition ESPEN 2022;47:45-50. [DOI: 10.1016/j.clnesp.2021.12.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Galica AN, Galica R, Dumitrașcu DL. Diet, fibers, and probiotics for irritable bowel syndrome. J Med Life 2022;15:174-9. [PMID: 35419092 DOI: 10.25122/jml-2022-0028] [Reference Citation Analysis]
24 Marlicz W, Skonieczna-Żydecka K, Krynicka P, Łoniewski I, Rydzewska G. Probiotics in irritable bowel syndrome - is the quest for the right strain over? Rapid review of existing guidelines and recommendations. Prz Gastroenterol 2021;16:369-82. [PMID: 34976247 DOI: 10.5114/pg.2021.111766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 何 婷. Progress in the Correlation between Percutaneous Acupoint Electrical Stimulation Therapy and Irritable Bowel Syndrome. ACM 2022;12:12008-12014. [DOI: 10.12677/acm.2022.12121730] [Reference Citation Analysis]
26 Lai Y, Chen C, Bair M. Epidemiology, Clinical Features, and Prescribing Patterns of Irritable Bowel Syndrome in Taiwan. Front Pharmacol 2021;12. [DOI: 10.3389/fphar.2021.788795] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Liu JJ, Brenner DM. Review article: current and future treatment approaches for IBS with constipation. Aliment Pharmacol Ther 2021;54 Suppl 1:S53-62. [PMID: 34927760 DOI: 10.1111/apt.16607] [Reference Citation Analysis]
28 Negrete-romero B, Valencia-olivares C, Baños-dossetti GA, Pérez-armendáriz B, Cardoso-ugarte GA. Nutritional Contributions and Health Associations of Traditional Fermented Foods. Fermentation 2021;7:289. [DOI: 10.3390/fermentation7040289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sugaya N, Shirotsuki K, Nakao M. Cognitive behavioral treatment for irritable bowel syndrome: a recent literature review. Biopsychosoc Med 2021;15:23. [PMID: 34838129 DOI: 10.1186/s13030-021-00226-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Masclee GMC, Snijkers JTW, Boersma M, Masclee AAM, Keszthelyi D. Patient preferences of healthcare delivery in irritable bowel syndrome: a focus group study. BMC Gastroenterol 2021;21:438. [PMID: 34814846 DOI: 10.1186/s12876-021-02030-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Otani K, Watanabe T, Higashimori A, Suzuki H, Kamiya T, Shiotani A, Sugimoto M, Nagahara A, Fukudo S, Motoya S, Yamaguchi S, Zhu Q, Chan FKL, Hahm KB, Tablante MC, Prachayakul V, Abdullah M, Ang TL, Murakami K; International Gastrointestinal Consensus Symposium Study Group. A Questionnaire-Based Survey on the Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy in Asia. Digestion 2022;103:7-21. [PMID: 34758472 DOI: 10.1159/000520287] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
32 Irving H, Turek I, Kettle C, Yaakob N. Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses. Int J Mol Sci 2021;22:11910. [PMID: 34769340 DOI: 10.3390/ijms222111910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Funaba M, Kawanishi H, Fujii Y, Higami K, Tomita Y, Maruo K, Sugawara N, Oe Y, Kura S, Horikoshi M, Ohara C, Kikuchi H, Ariga H, Fukudo S, Sekiguchi A, Ando T. Hybrid Cognitive Behavioral Therapy With Interoceptive Exposure for Irritable Bowel Syndrome: A Feasibility Study. Front Psychiatry 2021;12:673939. [PMID: 34566709 DOI: 10.3389/fpsyt.2021.673939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Nikitina EA, Orlova SV, Orlova AA. Probiotics: present and future. Medicinskij alfavit 2021. [DOI: 10.33667/2078-5631-2021-21-101-114] [Reference Citation Analysis]
35 Yan R, Andrew L, Marlow E, Kunaratnam K, Devine A, Dunican IC, Christophersen CT. Dietary Fibre Intervention for Gut Microbiota, Sleep, and Mental Health in Adults with Irritable Bowel Syndrome: A Scoping Review. Nutrients 2021;13:2159. [PMID: 34201752 DOI: 10.3390/nu13072159] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
36 Fukudo S, Kano M, Sato Y, Muratsubaki T, Kanazawa M, Tashiro M, Yanai K. Histamine Neuroimaging in Stress-Related Disorders. The Functional Roles of Histamine Receptors 2021. [DOI: 10.1007/7854_2021_262] [Reference Citation Analysis]